文献速递肺结节与肺癌

外周肺活检诊断阳性率与诊断准确性的比较:支持未来务实终点的证据

Diagnostic Yield vs Diagnostic Accuracy for Peripheral Lung Biopsy Evaluation: Evidence Supporting a Future Pragmatic End Point.
PubMed 文献 · Chest · 2023-12-22

研究基于2017至2019年导航支气管镜连续采样外周肺病灶的前瞻性数据集,比较不同诊断阳性率定义与2年随访确认的诊断准确性。结果显示,仅将恶性或特异性良性结果视为诊断的保守定义,其与准确性的差异仅0.7%,可近似替代准确性。

要点

  • 保守诊断阳性率定义(仅恶性或特异性良性)与2年随访准确性差异仅0.7%。
  • 非特异性良性活检中恶性假阴性率高达38.7%,不宜计入诊断阳性。
  • 该定义可加速先进支气管镜设备的诊断效用数据报告。

核心结论

  • 排除非特异性良性诊断的保守诊断阳性率定义与2年随访诊断准确性差异小于1%。
  • 该保守定义可作为未来先进诊断支气管镜研究的务实终点。

研究设计与样本

  • 前瞻性数据集中连续外周肺病灶导航支气管镜采样,2017至2019年。
  • 共分析450份病灶活检标本,恶性患病率60.9%(274/450)。

主要发现

  • 初始病理恶性诊断227例(50.4%),假阳性1例(0.4%)。
  • 特异性良性活检104例中恶性假阴性2例(1.9%)。
  • 非特异性良性活检119例中恶性假阴性46例(38.7%)。
  • 保守定义下诊断阳性率与准确性差异为0.7%。

关键数值与推荐

  • 保守定义仅将恶性或特异性良性结果视为诊断。

临床怎么用

  • 在先进诊断支气管镜研究中可采用保守诊断阳性率定义替代需长期随访的准确性终点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Diagnostic yield and accuracy endpoints have been used inconsistently in the evaluation of advanced diagnostic bronchoscopy devices and techniques, limiting between-study comparisons. In addition, diagnostic accuracy can be adjudicated only after prolonged clinical follow-up, which delays reporting on the performance of novel devices. RESEARCH QUESTION: Will a conservative diagnostic yield definition result in few false-negative initial results to closely approximate diagnostic accuracy and represent a useful outcome for future studies of diagnostic utility? METHODS: Commonly used definitions of diagnostic yield were applied to a prospective data set of consecutive peripheral pulmonary lesions sampled by navigational bronchoscopy from 2017 to 2019. All consider malignancy to be diagnostic but differ in their classification of nonmalignant biopsy findings, which were subcategorized as specific benign, nonspecific benign, or normal lung. Diagnostic yield calculations were also compared with diagnostic accuracy, defined as the proportion of biopsy specimens deemed diagnostic by each definition that were confirmed accurate through 2 years of follow-up. RESULTS: A total of 450 biopsy specimens of lesions were analyzed. The prevalence of malignancy was 60.9% (274 of 450). On initial bronchoscopy pathology, there were 227 malignant diagnoses (50.4%), with a single false positive (0.4%). Among 104 biopsy specimens with specific benign findings, only two were false negative for malignancy (1.9%). There were 119 nonspecific benign biopsy specimens, with 46 false negatives for malignancy (38.7%). The discrepancy between diagnostic yield and accuracy was 0.7% for the conservative definition, which only considered malignant or specific benign findings as diagnostic. INTERPRETATION: A conservative diagnostic yield definition excluding nonspecific benign diagnoses closely approximated diagnostic accuracy through 2 years' follow-up, with a less than 1% discrepancy. Using this conservative yield definition may allow for dissemination of reliable diagnostic utility data without protracted delays needed for follow-up data in this era of rapid technological change in advanced diagnostic bronchoscopy.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Leonard KM, Low SW, Echanique CS, et al. Diagnostic Yield vs Diagnostic Accuracy for Peripheral Lung Biopsy Evaluation: Evidence Supporting a Future Pragmatic End Point. Chest. 2023. PMID: 38142773. doi:10.1016/j.chest.2023.12.024

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。